Suppr超能文献

确保疫苗效力和供应:证据如何塑造 Gavi 的免疫供应链战略。

Ensuring vaccine potency and availability: how evidence shaped Gavi's Immunization Supply Chain Strategy.

机构信息

John Snow, Inc, Washington, DC, USA.

Gavi, the Vaccine Alliance, Geneva, Switzerland.

出版信息

BMC Health Serv Res. 2022 Oct 7;22(1):1237. doi: 10.1186/s12913-022-08616-9.

Abstract

BACKGROUND

In 2014, Gavi and partners developed a global Immunization Supply Chain (iSC) Strategy, 2015-2020, which prioritized functioning cold chain equipment (CCE) and additional storage capacity. In 2016, Gavi launched the Cold Chain Equipment Optimization Platform (CCEOP) as a funding mechanism to improve CCE availability. In 2018, Gavi commissioned an evaluation of CCEOP in Guinea, Kenya and Pakistan. The global iSC Strategy has recently been revised, drawing on findings from effective vaccine management assessments and practical experiences. This case study presents the CCEOP evaluation and how its findings reinforced the revision of the iSC strategy.

METHODS

The CCEOP evaluation used a prospective mixed-methods research design in all three countries involving key informant interviews at multiple levels of the health system, document reviews, direct observation (as and when possible), and a health facility assessment.

RESULTS

Results show that CCEOP was effective at increasing the number of available and reliable CCE, and establishing improved management processes using the project management team (PMT) approach for country management systems and the service bundle provider approach for installation and maintenance. CCEOP also extended the iSC and immunization services in countries. The evaluation results also show gaps in the overall supply chain system, including CCE maintenance.

DISCUSSION

Gavi has recently revised its iSC strategy, which has addressed gaps identified through assessments and practical experiences from stakeholders. Results of the CCEOP evaluation reinforce many of these findings. The strategy now provides more emphasis on supporting the fundamental infrastructure and establishing strong processes for maintenance. It also emphasizes strategic planning and forward thinking for iSC decisions, building on the processes established for the PMT through CCEOP. The original iSC strategy was an impetus for the establishment of CCEOP. The new strategy reflects shifting trends and priorities to fill gaps identified through practical experience, advocated for by stakeholders and thought leaders engaged in the iSC, and validated by the evaluation. It demonstrates the importance of aligning stakeholders with clear objectives and a sound strategy.

摘要

背景

2014 年,全球疫苗免疫联盟(Gavi)及其合作伙伴制定了 2015-2020 年全球免疫供应链(iSC)战略,该战略优先考虑冷链设备(CCE)的正常运行和额外的存储能力。2016 年,Gavi 推出了冷链设备优化平台(CCEOP),作为改善 CCE 可用性的供资机制。2018 年,Gavi 委托对 Guinea、Kenya 和 Pakistan 进行了 CCEOP 评估。最近,根据有效的疫苗管理评估结果和实践经验,对全球 iSC 战略进行了修订。本案例研究介绍了 CCEOP 评估及其结果如何强化 iSC 战略的修订。

方法

在所有三个国家,CCEOP 评估采用了前瞻性混合方法研究设计,涉及卫生系统多个层面的关键知情者访谈、文件审查、直接观察(在可能时)以及卫生设施评估。

结果

结果表明,CCEOP 成功地增加了可用和可靠的 CCE 数量,并通过项目管理团队(PMT)方法为国家管理系统和服务包供应商方法为安装和维护建立了改进的管理流程,从而扩展了国家的 iSC 和免疫服务。评估结果还显示了整个供应链系统中的差距,包括 CCE 维护。

讨论

Gavi 最近修订了其 iSC 战略,该战略解决了通过评估和利益攸关方的实践经验发现的差距。CCEOP 评估的结果强化了其中的许多发现。该战略现在更加注重支持基本基础设施和建立强大的维护流程。它还强调了 iSC 决策的战略规划和前瞻性思维,这是通过 CCEOP 为 PMT 建立的流程。最初的 iSC 战略是建立 CCEOP 的动力。新战略反映了通过实践经验、利益攸关方和参与 iSC 的思想领袖倡导以及评估验证的转变趋势和优先事项,以填补发现的差距。它展示了使利益攸关方与明确的目标和健全的战略保持一致的重要性。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/52eb/9540994/9db2f57ab7c1/12913_2022_8616_Fig1_HTML.jpg

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验